C
Chungyeul Kim
Researcher at Korea University
Publications - 64
Citations - 10232
Chungyeul Kim is an academic researcher from Korea University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 20, co-authored 54 publications receiving 9420 citations. Previous affiliations of Chungyeul Kim include University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Soonmyung Paik,Steven Shak,Gong Tang,Chungyeul Kim,Joffre B. Baker,Maureen T. Cronin,Frederick L. Baehner,Michael G. Walker,Drew Watson,Taesung Park,William Hiller,Edwin R. Fisher,D. Lawrence Wickerham,John Bryant,Norman Wolmark +14 more
TL;DR: The recurrence score has been validated as quantifying the likelihood of distant recurrence in tamoxifen-treated patients with node-negative, estrogen-receptor-positive breast cancer and could be used as a continuous function to predict distant recurrent in individual patients.
Journal ArticleDOI
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
Soonmyung Paik,Gong Tang,Steven Shak,Chungyeul Kim,Joffre B. Baker,Wanseop Kim,Maureen T. Cronin,Frederick L. Baehner,Drew Watson,John Bryant,Joseph P. Costantino,Charles E. Geyer,D. Lawrence Wickerham,Norman Wolmark +13 more
TL;DR: The RS assay not only quantifies the likelihood of breast cancer recurrence in women with node-negative, estrogen receptor-positive breast cancer, but also predicts the magnitude of chemotherapy benefit.
Journal ArticleDOI
HER2 Status and Benefit from Adjuvant Trastuzumab in Breast Cancer
TL;DR: To the Editor: Trastuzumab, an antibody against the protein product of the human epidermal growth factor receptor type 2 (HER2) gene, improves progression-free survival and overall survival when used in combination with chemotherapy.
Journal ArticleDOI
Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value
Patrick G. Gavin,Linda H. Colangelo,Debora Fumagalli,Noriko Tanaka,Matthew Y. Remillard,Greg Yothers,Chungyeul Kim,Yusuke Taniyama,Seung Il Kim,Hyun Joo Choi,Nicole L. Blackmon,Corey Lipchik,Nicholas J. Petrelli,Michael J. O'Connell,Norman Wolmark,Soonmyung Paik,Kay L. Pogue-Geile +16 more
TL;DR: This study shows that BRAF mutations profiled from stage II and III colon cancer tumors were associated with poor SAR and validates and explains, at least in part, previous observations associating it with poor OS.
Journal ArticleDOI
Gene-expression-based prognostic assays for breast cancer.
Chungyeul Kim,Soonmyung Paik +1 more
TL;DR: MammaPrint® and Oncotype DX®, two widely utilized assays are compared with respect to differences in the clinical contexts for their development, technologies used, and clinical utilities with the aim of providing a guide to clinical oncologists for utilization of these assays.